reference/9875730

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9875730

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase III\|Journal Article\|Randomized Controlled Trial
endingPage	1158
issn	0085-2538
issueIdentifier	3
pageRange	1153-1158
publicationName	Kidney International
startingPage	1153
bibliographicCitation	Izzedine H, Hulot JS, Launay-Vacher V, Marcellini P, Hadziyannis SJ, Currie G, Brosgart CL, Westland C, Arterbrun S, Deray G; Adefovir Dipivoxil International 437 Study Group; Adefovir Dipivoxil International 438 Study Group. Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies. Kidney Int. 2004 Sep;66(3):1153–8. doi: 10.1111/j.1523-1755.2004.00866.x. PMID: 15327411.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5717-1703 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80d967c6d1ebf22c917e219dbeadd98e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8310eb4240f50f9dfc6e16c018e4a3b8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5febe16eacb3537210f91309a26b3527 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96a9992c3b1343f41ff46e3a41f9a12f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e6c5e21c6f96566ac46e0e6302be38c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7acd3d1a43359b37336e3d0e4f677665 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_867c5d80b34563a0366d64ec6b31c0dc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51b4ba5df6d18b6b8155fe6a288626f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50c47eb8c33e5e58e1241bfdff5ae0a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27a2376d6679b1c8a5f72a8f4b55b047
date	200409
identifier	https://doi.org/10.1111/j.1523-1755.2004.00866.x https://pubmed.ncbi.nlm.nih.gov/15327411
isPartOf	https://portal.issn.org/resource/ISSN/0085-2538 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5428
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: Two double-blind, randomized, placebo-controlled studies
discusses	http://id.nlm.nih.gov/mesh/M0571031 http://id.nlm.nih.gov/mesh/M0016721 http://id.nlm.nih.gov/mesh/M0000347 http://id.nlm.nih.gov/mesh/M0005300 http://id.nlm.nih.gov/mesh/M0001518 http://id.nlm.nih.gov/mesh/M0278180
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006417Q000139 http://id.nlm.nih.gov/mesh/D063065 http://id.nlm.nih.gov/mesh/D000998Q000009 http://id.nlm.nih.gov/mesh/D019694Q000188 http://id.nlm.nih.gov/mesh/D000225Q000009 http://id.nlm.nih.gov/mesh/D000225Q000031 http://id.nlm.nih.gov/mesh/D007668Q000187
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011507Q000139 http://id.nlm.nih.gov/mesh/D000998Q000008 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D010758Q000097 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000225Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006029Q000139 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D003404Q000097
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7952 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8235 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7860 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60871 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462309 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8349 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10398 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8989 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10064

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127945305 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129613204 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861

Total number of triples: 66.